menu toggle

Manufacturer Solutions

Cell and Gene Therapy

Connecting innovators across the advanced therapy supply chain

We look forward to hearing from you

Your partner in moving health forward

Groundbreaking cell and gene therapies are paving the path to a healthier tomorrow. And because these life-changing products require equally innovative commercialization partners, AmerisourceBergen is committed to solutions that light the way so that your product reaches the patients who need it.

Schedule time with our experts to discuss: 

  • Outcomes based agreements
  • Global courier services
  • 3PL Logistics 
  • Distribution
  • Market access and reimbursement
  • Patient support

Cell and gene therapy insights

Cell and Gene therapy alternative reimbursement models

Insight

Webinar: Evaluate alternative revolutionary reimbursement models to craft a sustainable business model for cell and gene therapies

David Senior
AmerisourceBergen
December 2022

Reimbursement models for CGT

Insight

Evaluating alternative revolutionary reimbursement models to craft a sustainable business model for cell and gene therapies

David Senior
AmerisourceBergen
October 2022

Cell and gene therapy Alternate payer engagement models

Insight

Alternate payer engagement models are changing the landscape


AmerisourceBergen
August 2022